期刊文献+

凋亡相关基因在眼眶腺样囊性癌组织中的表达意义 被引量:1

Expression of of P53 and Bcl-2 in orbital adenoid cystic carcinoma
下载PDF
导出
摘要 目的:分析凋亡相关基因p53和bcl-2在眼眶腺样囊性癌组织中的表达,分析其关系及临床意义。方法:免疫组化法检测51例眼眶腺样囊性癌临床标本和10例正常眼眶组织中P53和Bcl-2蛋白的表达状况。结果:P53和Bcl-2在眼眶腺样囊性癌组织中的表达阳性率分别为53%和65%,显著高于眼眶正常组织(53%,65%vs10%,P<0.01)。实性型腺样囊性癌中P53的表达率显著高于其在腺样-管状型中的表达率(86%vs30%,P<0.01);P53和Bcl-2在复发组中的表达率显著高于其在初发组中的表达率(85%vs42%,P<0.01),(100%vs53%,P<0.01);P53和Bcl-2二者在表达上具有相关性(χ2=1.461,P>0.05)。结论:P53和Bcl-2蛋白的检测对于判断肿瘤对化疗的敏感性和预后有参考价值。 AIM: To study the expression and clinical significances of P53 and Bcl-2 in orbital adenoid cystic carcinoma, and to provide theoretical information and clinical references for evaluating the prognosis of orbital adenoid cystic carcinoma. METHODS: The expression of P53 and Bcl-2 in 51 cases of orbital adenoid cystic carcinoma and 10 cases of normal orbital tissues were detected by immunohistochemisry analysis. RESULTS: P53 and Bcl-2 expression percentage were 53% and 65% respectively in orbital adenoid cystic carcinoma and were higher than in normal orbital tissues (vs 10%, P〈 0.01 ). The positive rate of P53 expression in adenoid-tubular ACC was higher than in solid ACC (86% vs 30%,P〈0.01). The positive rate of P53 and Bcl-2 expression in recurrent tumor group was higher than in primary tumor group (85% vs 42%, P〈0.01) (100% vs 53%, P〈0.01). Significant correlation was found between the expression of P53 and Bcl-2 (X^ 2=1.461, P 〉0.05). CONCLUSION: The overexpressions of P53 and Bcl-2 were participated in the acquired drug resistance in orbital adenoid cystic carcinoma, and the detection were of great value in the prognosis evaluation.
出处 《国际眼科杂志》 CAS 2006年第4期799-801,共3页 International Eye Science
关键词 眼眶腺样囊性癌 凋亡相关基因 耐药 orbital adenoid cystic carcinoma apoptosis-associated gene drug resistance
  • 相关文献

参考文献11

二级参考文献41

  • 1Shieds JA,Shields CL,Epstein JA,Scartozzi R,Eagle RC.Primary epithelial marlignancies of the lacrimal gland:the 2003 Ramon L.Font Lecture.Ophthal Plast Reconstr Surg,2004 ;20( 1 ):10-21
  • 2Goffinet DR,Martinez A,Fee WE Jr.125I vicryl suture implants as a surgical adjuvant in cancer of the head and neck.Int J Radiat Oncol Biol Phys,1985; 11 (2):399
  • 3Park RI,Liberman FZ,Lee DJ.125I seed implantation as an adjunct to surgery in advanced recurrent squamous cell cancer of the head and neck.Laryngoscope,1991; 101 (4)405
  • 4Shields JA,Shields CL,Freire JE,Brady LW,Komarnicky L.Plaque radiotherapy for selected orbital malignancies:preliminary observations.Ophthal Plast Reconstr Surg,2003;19(2):91-95
  • 5Bice WS Jr,Prestidge BR,Prete JJ.Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I.American Association of Physicists in Medicine.Int J Radiat Oncol Biol Phys,1998 ; 40( 5):123 7
  • 6Mendenhall WM,Morris CG,Amdur RJ,Werning JW,Hinerman RW,Villaret DB.Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and nack.Head &amp; Neck,2004;(26):154-162
  • 7Meldrum ML,Tse DT,Benedetto P.Neoadjuvant intracarotid chemotherapy for treatment of advanced adenoidocystic carcinoma of the lacrimal gland.Arch Ophthalmol,1998;116(3):315-321
  • 8Goldberg RA.Intra-arterial chemotherapy:a welcome new idea for the lacrimal gland.Arch Ophthalmol,1998;116(3):372-373
  • 9Sehulz-Ertner D,Nikoghosyan A,Thilmann C,Haberer T,Jakel O,Karger C,Kraft G,Wannenmacher M,Debus J.Results of carbon ion radiotherapy in 152 patients.Int J Radiat Oncol Biol Phys,2004;58(2):631-640
  • 10National Cancer Institute (NCI).Common toxicity criteria.Bethesda,MD:Division of Cancer Treatment,National Cancer Institute,1988

共引文献29

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部